Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback Home
Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 53% Improvement Relative Risk ICU admission 35% Hospitalization 42% c19early.com/ex Rahmati et al. Exercise for COVID-19 META ANALYSIS Favors exercise Favors inactivity
Rahmati, exercise meta analysis: 53% lower mortality [p=0.001], 35% lower ICU admission [p=0.001], and 42% lower hospitalization [p=0.001] https://c19p.org/rahmati
copied to clipboard
Baseline physical activity is associated with reduced mortality and disease outcomes in COVID‐19: A systematic review and meta‐analysis
Rahmati et al., Reviews in Medical Virology, doi:10.1002/rmv.2349 (meta analysis)
13 Apr 2022    Source   PDF   Share   Tweet
Meta analysis of 12 physical activity and COVID-19 studies, showing lower mortality, ICU admission, and hospitalization with physical activity.
Currently there are 33 exercise for COVID-19 studies, showing 44% [33‑53%] lower mortality, 46% [32‑57%] lower ventilation, 41% [34‑47%] lower ICU admission, 42% [19‑58%] lower hospitalization, and 20% [11‑28%] lower cases.
risk of death, 53.0% lower, RR 0.47, p = 0.001.
risk of ICU admission, 35.0% lower, RR 0.65, p = 0.001.
risk of hospitalization, 42.0% lower, RR 0.58, p = 0.001.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Rahmati et al., 4/13/2022, peer-reviewed, 10 authors.
All Studies   Meta Analysis
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit